ASTM F2347-03 - 1.11.2003
 
Significance and Use

This guide contains a listing of those characterization parameters that are directly related to the functionality of hyaluronan. This guide can be used as an aid in the selection and characterization of the appropriate hyaluronan for a particular application. This guide is intended to give guidance in the methods and types of testing necessary to properly characterize, assess, and ensure consistency in the performance of a particular hyaluronan. It may have use in the regulation of these devices by appropriate authorities.

The hyaluronan covered by this guide may be gelled, cross-linked, extruded, or otherwise formulated into biomedical devices for use in tissue engineered medical products or drug delivery devices for implantation as determined to be appropriate, based on supporting biocompatibility and physical test data. Recommendations in this guide should not be interpreted as a guarantee of clinical success in any tissue engineered medical product or drug delivery application.

To ensure that the material supplied satisfies requirements for use in TEMPs, several general areas of characterization should be considered. These are: identity of hyaluronan, physical and chemical characterization and testing, impurities profile, and performance-related tests.

 
1. Scope

1.1 This guide covers the evaluation of hyaluronan suitable for use in biomedical or pharmaceutical applications, or both, including, but not limited to, Tissue Engineered Medical Products (TEMPs).

1.2 This guide addresses key parameters relevant to the characterization and purity of hyaluronan.

1.3 As with any material, some characteristics of hyaluronan may be altered by processing techniques, such as cross-linking and sterilization, required for the production of a specific formulation or device. Therefore, properties of fabricated forms of this polymer should be evaluated using test methods that are appropriate to ensure safety and efficacy and are not addressed in this guide.

1.4 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory requirements prior to use.

 
2. Referenced Documents

E1953-20

Standard Practice for Description of Thermal Analysis and Rheology Apparatus

E2975-23

Standard Test Method for Calibration or Calibration Verification of Concentric Cylinder Rotational Viscometers

F895-11(2016)

Standard Test Method for Agar Diffusion Cell Culture Screening for Cytotoxicity

F619-20

Standard Practice for Extraction of Materials Used in Medical Devices

F748-16

Standard Practice for Selecting Generic Biological Test Methods for Materials and Devices

F749-20

Standard Practice for Evaluating Material Extracts by Intracutaneous Injection in the Rabbit

F756-17

Standard Practice for Assessment of Hemolytic Properties of Materials

F763-22

Standard Practice for Short-Term Intramuscular Screening of Implantable Medical Device Materials

F813-20

Standard Practice for Direct Contact Cell Culture Evaluation of Materials for Medical Devices

F1903-18

Standard Practice for Testing for Cellular Responses to Particles in vitro

F1439-03(2018)

Standard Guide for Performance of Lifetime Bioassay for the Tumorigenic Potential of Implant Materials

F1904-23

Standard Guide for Testing the Biological Responses to Medical Device Particulate Debris and Degradation Products in vivo

F981-23

Standard Practice for Assessment of Muscle and Bone Tissue Responses to Long-Term Implantable Materials Used in Medical Devices